Abstract
Palliative radical (cysto-)prostatectomy is associated with a median symptom-free survival which covers 75-80% of the remaining lifetime in patients with symptomatic locally advanced castration-resistant prostate cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
